PLEASE REGISTER ONLINE AT: PUMAREG.TSGMEDED.COM Enter Event Code:51684
This program is sponsored by Puma Biotechnology, Inc. This is not an independent educational program, and no CME credits will be provided.
ADVERSE REACTIONS: The most common adverse reactions (reported in ≥ 5% of patients) were:
NERLYNX as a single agent: diarrhea, nausea, abdominal pain, fatigue, vomiting, rash, stomatitis, decreased appetite, muscle spasms, dyspepsia, AST or ALT increased, nail disorder, dry skin, abdominal distention, epistaxis, weight decreased, and urinary tract infection.
NERLYNX in combination with capecitabine: diarrhea, nausea, vomiting, decreased appetite, constipation, fatigue/asthenia, weight decreased, dizziness, back pain, arthralgia, urinary tract infection, upper respiratory tract infection, abdominal distention, renal impairment, and muscle spasms.